Keeps Biopharma Inc. (256940.KQ)
- Previous Close
12,790.00 - Open
0.00 - Bid --
- Ask --
- Day's Range
0.00 - 0.00 - 52 Week Range
0.00 - 12,790.00 - Volume
0 - Avg. Volume
256,384 - Market Cap (intraday)
239.796B - Beta (5Y Monthly) 1.33
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 27, 2018
- 1y Target Est
13,000.00
Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products. The company is also involved in bio research and development business; waste battery recycling; and other non-ferrous metal smelting, refining, and alloy manufacturing. The company was formerly known as KPS Corporation and changed its name to Keeps Biopharma Inc. in April 2025. Keeps Biopharma Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.
www.kpscorp.co.kr--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 256940.KQ
View MorePerformance Overview: 256940.KQ
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 256940.KQ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 256940.KQ
View MoreValuation Measures
Market Cap
221.61B
Enterprise Value
254.36B
Trailing P/E
200.34
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.75
Price/Book (mrq)
4.42
Enterprise Value/Revenue
1.99
Enterprise Value/EBITDA
26.27
Financial Highlights
Profitability and Income Statement
Profit Margin
0.87%
Return on Assets (ttm)
2.76%
Return on Equity (ttm)
2.65%
Revenue (ttm)
127.58B
Net Income Avi to Common (ttm)
1.11B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
22.99B
Total Debt/Equity (mrq)
88.16%
Levered Free Cash Flow (ttm)
21.08B